Maria Sundvall

8PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisTumour immunologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 01, 2026
Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.

|Jun 25, 2026
Comparison of [18F]DCFPyL and [18F]FAPI-74 PET/CT imaging in metastatic prostate cancer.

|Oct 06, 2025
Androgen receptor-mediated regulation of BRCA1 modulates the antioxidant defense in prostate cancer.

Saiganesh Sriraman, Verneri Virtanen, Antti Kukkula

|Nov 02, 2024
xCT as a Predictor for Survival in a Population-Based Cohort of Head and Neck Squamous Cell Carcinoma.

Linda Nissi, Sanni Tuominen, Johannes Routila

|May 25, 2024
Phage Biosensor for the Classification of Metastatic Urological Cancers from Urine.

Vilhelmiina Juusti, Antti Rannikko, Anu Laurila

|May 22, 2024
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity.

Miriam Langguth, Eleftheria Maranou, Saara A Koskela

Pageof 2

Frequent Collaborators

3 joint publications

Heikki Minn

2 joint publications

Anniina Hyväkkä

2 joint publications

Verneri Virtanen

1 joint publications

Saana Niva